Penicillin

Hospira finally completes Orchid plant acquisition

Hospira finally completes Orchid plant acquisition

By Gareth Macdonald

Hospira has paid Orchid Chemicals and Pharmaceuticals $218m (€160m) for an API plant in Aurangabad, India to increase its antibiotics production capacity and cut reliance on external suppliers.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers